Literature DB >> 1311181

Peripheral noradrenergic function during chronic lithium treatment in the rat.

J P Finberg1, I Kremer, I Spanir, R H Lenox, E Klein.   

Abstract

Noradrenergic function was evaluated in the rat vas deferens following chronic treatment with lithium (30 mM in the diet for 2 weeks followed by 50 mM for 1 week). No alteration could be detected in: a) 3H-noradrenaline release evoked by electrical field stimulation, b) alpha 1-adrenoceptor function as assessed by contractile response to noradrenaline, c) active neuronal uptake of 3H-noradrenaline, d) alpha 2-adrenoceptor activity, as assessed by yohimbine-enhancement of evoked release of 3H-noradrenaline. The data argue against a primary action of lithium on the noradrenergic nerve. On the other hand, these findings do not rule out the possibility that the function of CNS noradrenergic neurons could be altered as a result of the known effects of lithium on the phosphatidyl-inositol system, and the greater sensitivity of CNS neurons to depletion of the neuronal membrane inositol pool.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1311181     DOI: 10.1007/bf01253112

Source DB:  PubMed          Journal:  J Neural Transm Gen Sect


  16 in total

1.  Investigation of the mechanism of decreased sensitivity of the rat seminal vesicle to norepinephrine by lithium.

Authors:  P D Patel; D S Shah; S R Patel; O D Gulati
Journal:  Pharmacology       Date:  1979       Impact factor: 2.547

2.  Fluoride-stimulated adenylate cyclase activity in rat brain following chronic treatment with psychotropic drugs.

Authors:  P H Andersen; R Klysner; A Geisler
Journal:  Neuropharmacology       Date:  1984-04       Impact factor: 5.250

3.  The effect of repeated electroconvulsive shock treatment and chronic lithium feeding on the release of norepinephrine from rat cortical vesicular preparations.

Authors:  R P Ebstein; B Lerer; M Shlaufman; R H Belmaker
Journal:  Cell Mol Neurobiol       Date:  1983-09       Impact factor: 5.046

4.  Does lithium in vitro and ex vivo alter the release of [3H]noradrenaline from brain tissue and the sensitivity of presynaptic autoreceptors?

Authors:  G Gross; G Hanft
Journal:  Neuropharmacology       Date:  1990-09       Impact factor: 5.250

5.  Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands.

Authors:  M J Berridge; C P Downes; M R Hanley
Journal:  Biochem J       Date:  1982-09-15       Impact factor: 3.857

6.  The effect of lithium on noradrenaline-induced cyclic AMP accumulation in rat brain: inhibition after chronic treatment and absence of supersensitivity.

Authors:  R P Ebstein; M Hermoni; R H Belmaker
Journal:  J Pharmacol Exp Ther       Date:  1980-04       Impact factor: 4.030

7.  Effect of chronic lithium administration on adrenoceptor binding and adrenoceptor regulation in rat cerebral cortex.

Authors:  G Gross; C Dodt; G Hanft
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-03       Impact factor: 3.000

8.  Alpha-1 adrenergic receptor binding and adrenergic-stimulated cyclic AMP production in rat cerebral cortex after chronic lithium treatment.

Authors:  T L Casebolt; X H Li; R S Jope
Journal:  J Neural Transm Gen Sect       Date:  1990

9.  Action of lithium on the adrenergic nerve ending.

Authors:  O Beaty; M G Collis; J T Shepherd
Journal:  J Pharmacol Exp Ther       Date:  1981-08       Impact factor: 4.030

10.  Evoked release of norepinephrine and serotonin from brain slices: inhibitoon by lithium.

Authors:  R I Katz; T N Chase; I J Kopin
Journal:  Science       Date:  1968-10-25       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.